Type
. In vivo and in vitro drug metabolism in patients with leprosy. Leprosy in India. 1982;54(1):75-81.
Type
. Absence of antibodies to muramyl dipeptide in patients with tuberculosis or leprosy. Clinical and experimental immunology. 1982;47(1):53-8.
Type
. [Tuberculoid therapy in the migrant population of Maresme, Catalonia]. Medicina clinica. 1983;81(1):40.
Type
. Immunogenetics of susceptibility to leprosy, tuberculosis, and leishmaniasis. An epidemiological perspective. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 1981;49(4):437-54. Available from: http://ila.ilsl.br/pdfs/v49n4a09.pdf
Type
. [At a scene of life and death. 12. Life of a nurse caring for leprosy patients]. Kangogaku zasshi. 1981;45(12):1413-5.
Type
. The six disease of WHO. British medical journal (Clinical research ed.). 1981;283(6302):1320-2.
Type
. [Surgical treatment of the paralytic leprous foot. Apropos of 8 cases treated in New Caledonia]. Acta leprologica. 1981;85:93-7.
Type
. [Is there a reactivation of cellular immunity in erythema nodosum leprosum?]. Acta leprologica. 1981;85:83-92.
Type
. [Efficacy of a daily dosage of dapsone combined with a single dose of rifampicin. Clinical, bacteriological and histopathological evaluation]. Acta leprologica. 1981;85:75-82.
Type
. [Therapy of tuberculoid and borderline leprosy by specific progressive desensitization to lepromin. Comparison between the classic method of progressive dilutions and the use of lepromin retard in aluminum hydroxide]. Acta leprologica. 1981;85:69-74.